text:
Key factsPrint summary
An un-abused doctor owned example finished Metallic silver with black leather. It is in amazing condition throughout and must be one of if not the best example of the Mazda RX-8 available. This car has been extremely well kept and with what can only be described as an open cheque book approach to maintenance as shown by its Full Mazda main dealer service history and that all 4 tyres are the correct and matching Bridgestone Potenza recommended by Mazda. It drives flawlessly without any issues starts first time every time regardless of if hot or cold. 2 keys full handbook, 4 owners from new. We have carried out a new MOT test with only one advisory for an exhaust bracket. We will also carry out a service prior to collection by the next lucky owner. We welcome Part exchanges and we we will include a 6 month warranty with roadside assistance. All major debit and credit cards accepted subject an admin fee. 07805212324 www.carsnorthwest.co.uk , 6 months warranty, Next MOT due 15/05/2020, Last serviced on 16/05/2019, Full service history, Excellent bodywork, Black Full leather interior - Excellent Condition, Tyre condition Excellent, Metallic Silver, 4 owners, Available 7 days 9AM - 9PM on 07805212324, £2,000 p/x welcome
This car comes with
Metallic Paint, Leather Upholstery Seats Powered & Heated, Alarm, Alloy Wheels (18in), Climate Control, Cruise Control, Electric Windows (Front), In Car Entertainment (Radio/CD Autochanger)
- 201904187129638
- 2007
- 56
- £2,000
- 200
- 82,000
- Cars
- b5LrgHtZrWY=
Vehicle summary
|Body style
|Engine size
|1308 cc
|Fuel type
|Number of doors
|Number of seats
|Gearbox type
|CO2 emissions
|284 g/km
|Insurance group
|Standard manufacturer's warranty (miles)
|60000 miles
|Standard manufacturer's warranty (years)
|3 years
|Standard paintwork guarantee
|3 years
Performance & economy
|Fuel consumption (urban)
|17.9 mpg
|Fuel consumption (extra urban)
|31.7 mpg
|Fuel consumption (combined)
|24.8 mpg
|0 - 60 mph
|6.4 seconds
|Top speed
|146 mph
|No details available
|No details available
|Engine power
|228 bhp
|Engine torque
|155.60 lbs/ft
|1340 mm
|Height inclusive of roof rails
|No details available
|4435 mm
|2700 mm
|1771 mm
|Width including mirrors
|No details available
|Fuel tank capacity
|61 litres
|Minimum kerb weight
|1350 kg
|Interior features
|Exterior features
|Adjustable Steering Column/Wheel
|Alloy Wheels (18in)
|Climate Control
|Body Coloured Bumpers
|Electric Windows (Front)
|Mirrors External
|In Car Entertainment (Radio/CD Autochanger)
|Seat Height Adjustment
|Upholstery Cloth
|Air Bag Driver
|Air Bag Passenger
|Air Bag Side
|Anti-Lock Brakes
|Central Door Locking
|Front Fog Lights
|Head Restraints
|Power-Assisted Steering
|Seat - ISOFIX Anchorage Point (Two Seats - Rear)
Please note
This includes MPG figures which are calculated under European Standards, in test conditions, and will vary under normal driving conditions. The information displayed above describes the typical specification of the most recent model of this vehicle. It is not the exact specification for the actual vehicle being offered for sale which may vary. Specifications for older models may also vary. Please contact us prior to purchase to confirm the exact specification of this vehicle.
Thank you for contacting us!
We will aim to get back to you as soon as possible.
There was a problem sending your email.
There may be a technical issue.
Please try again later.


text:
Make Way for Way2
Posted on 08th Dec 2015
It is time for us to announce a new beginning. We have been preparing for it for long and the moment is now ripe for us to take off from the launch pad onto a real exciting form. First of all, we are becoming leaner with our app name. And second, we are becoming keener with offering much more than just sms to our audience. With the new name comes the second bit, the keener part. This part is what is going to give a whole new dimension to our changing identity while continuing with our erstwhile service of free sms. way2 is an app that brings to you short summarized nuggets of news in local languages, in a magazine style format. Way2 will offer short news bytes in Hindi, Marathi, Malyalam, Tamil, Bangla, Gujarati, Telugu and Kannada, as also in English. Way2 editors scour multiple news sources, local dailies, TV news channels, websites and blogs, RSS feeds, magazines and summarize each news story in just 400 characters. The idea is to enable the reader to assimilate all the major occurrences across the world without having to spend too much time poring over lengthy articles. However, in case the reader wants to read further, there is the option of going to the original site for exploring the news in greater detail.
The genesis of offering this new product is that we want to become an essential part of our consumers daily lives like we already have with way2sms. Way2 gets over 400,000 visitors a day and sees 12,000 new downloads. News consumption is a daily habit for most people. Also a huge chunk of people may have access to the Net but not to news in their local language. With way2, we are foraying into the large untapped segment of news readers who want to consume news in their native language.
With a 45 million strong user base we have the aspiration to become a matter of habit for our users. The local language user base has increased by 47 per cent in June 2015 (as compared to June 2014). The next surge of Internet users will be from the rural and suburban areas who would want more content in the vernacular. And with news being the most essential of all content, way2 seeks to fulfill the need of this particularly huge segment.
So there s lot of excitement and promise as also there is lot of research and diligence as we go live with way2. Considering the multitude of mobile phone devices with differing viewing windows, coupled with varied availability of internet across India s geography, Way2 faced a huge challenge with respect to ensuring seamless viewing. The Way2 app that you see has undergone hundreds of hours of testing on various devices, to ensure uninterrupted reading pleasure. To access Way2: It s pretty simple. Search for Way2News app, click download, confirm phone authentication with provided access number, and Way2 is all set. You can customize the app for language, subjects you prefer reading about, and also search current and previous posts about any topic/subject.
Leave Comment
No Comments
News Room

subset: commoncrawl


text:
MBC joins GRI in promoting Sustainability Reporting
Leaders and key players from the private sector gathered for the 2018 Global Reporting Index (GRI) Sustainability Summit held last October 8 at the Conrad Hotel, Manila. With the theme "Together Towards a Sustainable Philippines", the summit was aimed at providing a forum for companies to discuss key issues and latest trends on sustainability in business.
The event kicked off with a high-level breakfast meeting among business executives, where they discussed the important role of private sector in achieving the Sustainable Development Goals. Different sessions featured how sustainability is practiced across different business segments – from financing, manufacturing down to supply chains – and the impact and key challenges of sustainability reporting. Sustainability reporting enables companies to understand their impact on various stakeholders, and informs their decision-making to ensure long-term benefits on economy, society, and environment.
The GRI Sustainability Summit was organized by SM Investments Corp. and Australian Embassy of the Philippines, and supported by the Philippine Business Environment and the Makati Business Club. GRI is the organization behind the Sustainability Reporting Standards which is the first and most widely adopted global standards for sustainability reporting.


text:
Communism and British Intellectuals
Communism and British Intellectuals
The limitations of this survey--apart from the defects of my own analysis and synthesis--are the limitations of "social science" with its abstraction of human experience. "Man" in social science tends to be less of a concrete individual of flesh and blood who feels, thinks, and acts, than an artifice that "behaves". If there is no escape from abstraction, at least some of its excesses can be avoided. But even if I have succeeded in this, what remains can at best be only an intimation, never a revelation, for the "ultimate explanation" of the appeal of communism is forever concealed from rational enquiry in the minds and hearts of many diverse individuals.
An important motive in my writing has been a continual concern with the problem of wisdom and the exercise of political power. If political philosophy is to be written in and for the present scientific age, such a problem will be of paramount consideration. In his approach to the human predicament the political philosopher will have to deal with the impact of science upon society and government, with the intellectual in politics, and with many related questions. I hope that I have been able to furnish a fraction of the grist for the mill of such philosophy.
The term "intellectual" has been employed in the following pages in a very unscientific fashion. It is, perhaps, a concept just as useful and meaningful as "class" and just as difficult to define precisely. The intellectuals whom I discuss are chiefly men of literature and science who have been articulate about man, society and nature, and who have left a written record of their thoughts. The expression, "communist intellectual" does not necessarily indicate a person who is or has been a member of the Communist Party, but may refer to anyone who over a period of some time has . . .


text:
Want to use this letter?
Searching for a good job in the retail field? From part time cashiers to store managers, there are plenty of excellent positions available for qualified, motivated people. The retail-orientated cover letter examples below are designed to help you create an outstanding cover letter that can help you land the retail job youÃre looking for, sooner. Just choose any of the cover letter examples below to get started, and take the next step toward a rewarding new job.
Timothy Dunn
61 Wellfield Road
Roath, Cardiff CF4 3DG
Mobile: 07956 654 326
E-Mail: firstname.lastname@example.com
Dear Mr. Jacobson,
Looking for a dynamic Retail associate? Search no further, because I am ready for the job. With over 10 years' experience as in retail environments, I will step in and make an immediate contribution to Jacobson Gun Shop's continued success.
You are seeking someone who can proficiently sell products and services whilst maintaining first-rate customer service standards, and that is exactly what I am prepared to do. As a retail professional, I maintain thorough knowledge of all offerings and consistently exceed sales expectations through proactive consultative sales techniques. In addition, I am a proficient multi-tasker, have a stock background, and am familiar with loss prevention techniques.
I look forward to meeting with you in person this week and discussing the details of this position. In the meantime, please find my CV attached. References are available upon request.
Timothy Dunn


text:
Are you feeling stressed, depressed? Click to get info
Are you feeling stressed, depressed, anxious or have recently gone through a bereavement? Call Waltham Forest Talking Therapies (WFTT) on 0300 300 1554. WFTT is a free and confidential NHS service.
See below for helpful tips for dealing with stress, and services in Waltham Forest.
Why not take Mental Health Foundation's stress test, designed using the evidence-based perceived stress scale?
Tips for protecting from stress Click to get info
1. Connect with Others
If you're feeling too stressed, connecting with others or talking to someone can really help. You could start by talking to a trusted friend or family member about how you feel.
Your GP may be able to support you with getting the help you need such as free Cognitive Behavioural Therapy (CBT), a talking-based treatment for managing their difficult feelings.
Most workplaces have an independent confidential line that may offer support on a wide range of issues including managing workloads, debt, marital issues, performance, productivity and other issues that may affect our employees.
2. Be active
Being physically active releases feel good hormones called endorphins and can help you feel good and sleep better – helping to lower stress levels.
Try and integrate physical exercise into your lifestyle, even just going out and getting some fresh air, and taking some light physical exercise, like going for a walk to the shops can really help.
3. Take time out, have fun
Take time to relax and do the things that make you happy. Strike the balance between responsibility to others and responsibility to yourself, this can really reduce stress levels.
Make time for fun and relaxation, and try to do something you enjoy every day. Find a way of being active that you like.
Visitwww.mentalhealth.org.ukfor more tips on managing and dealing with stress
4. Give
Giving your time, words or your presence can make a world of difference for someone who may be going through a hard time.
Even in a busy environment like the work place, simply checking in on a colleague, asking how they are or offering to join in a lunch break can help someone through a stressful day.
Five ways to wellbeing Click to get info
Some important facts Click to get info
Research from the Health and Safety Executive (HSE) in 2016/17 found that over 500,000 workers suffer from work-related stress, depression or anxiety and that depression or anxiety accounted for 40% of all work-related ill health cases and 49% of all working days lost due to ill health.
Local services to promote good mental health Click to get info
In Waltham Forest there are various activities and services which will enable you thrive and maintain good mental health ranging from sports to talking therapies. Here are a few
- Talking Therapies offer psychological support for adults experiencing a range of mental health difficulties.
- Good Thinking is a free digital mental wellbeing service to help people to self-assess and self-manage their mental wellbeing issues online resources, mindfulness training and live peer to peer forums.
- Samaritans phone lines are open 24 hours a day, 365 days a year for those who need someone to talk to about their problems. You can call their free line on 116 123.
- Flourish offer emotional support to mothers after they have given birth
- Our Parks offer various activities every day for free in Waltham Forest, such as Dance Fit, Pilates, Social Sport, Yoga and more.
- Enjoy Waltham Forest have various walks, cycling and football events for the family this May.
- Coping Through Football, a project led jointly by Leyton Orient Trust and NELFT, offer football activities to young people and adults who experience social exclusion.
For more information contact Monica: firstname.lastname@example.com.


text:
Thursday 11 October 2012
October 11, 2012
Smartphone App Lets Russians Call Out Bribes
A group of young Muscovite entrepreneurs have launched a new mobile-phone application that allows users to report bribes to a central database. The app logs the reports and places them on an interactive map that will, its creators hope, spark a sense of civic responsibility in a public faced with widespread day-to-day corruption.
October 11, 2012
Documents Link Uzbekistan's Karimova To Money-Laundering Suspect
New documents uncovered by Swedish journalists in France link Gulnara Karimova, the millionaire daughter of autocratic Uzbek President Islam Karimov, with an Uzbek citizen under investigation for money laundering and other financial crimes in Switzerland and Sweden.
October 10, 2012
The Pakistani Taliban's Rationale For Shooting A Schoolgirl
In a letter issued following international condemnation of the shooting of Malala Yousafzai in Pakistan's northwestern Swat Valley, the Tehrik-i Taliban Pakistan (TTP) states its case for the attack and threatens anyone who challenges its strict interpretation of Shari'a law.
October 09, 2012
Profile: Shot Pakistani Teen Stood Up To The Taliban
Malala Yousafzai is a teenage girl from Pakistan's Swat district who stood up to the Taliban by writing an online diary about their ban on girls' schools there. On October 9, she was shot in the head and neck by a Pakistani Taliban gunman while traveling home from her school. RFE/RL takes a closer look at how the words of a brave young girl became a threat to Pakistan's Taliban.
October 09, 2012
News Analysis: Ivanishvili And The Russians
Newly nominated Prime Minister-designate Bidzina Ivanishvili has said he will seek to improve Georgia's relations with Russia yet maintain his predecessor's pro-Western policy. What do his cabinet choices tell us about his ability to find the middle path between confrontation and capitulation?
October 09, 2012
Agreeing To Disagree: The U.S. Election And One Middle Class Couple
He's voting Republican and she's voting Democrat. It's an understatement to say that George and Abreen Marountas don't agree on the important issues in the upcoming U.S. presidential election. But as this Afghan-Greek-American couple told correspondent Heather Maher, they love each other and agree to disagree.
October 08, 2012
Lincoln Mitchell: New Georgia Cabinet Is A Change Of Style And Substance
Lincoln Mitchell, an associate professor of international politics at Columbia University's Harriman Institute and head of the National Democratic Institute's Georgian office from 2002-04, served as an adviser to the Georgian Dream coalition during the recent election campaign. RFE/RL spoke to him about the cabinet nominees put forward by Georgian Dream leader Bidzina Ivanishvili on Monday and the prospects for a shift in relations with Russia.
October 08, 2012
In Steubenville, Livelihoods And Votes Are On The Line
Steubenville, Ohio is an average American city that has fallen on hard times -- and the kind of place where the 2012 presidential election may be won or lost. RFE/RL correspondent Richard Solash walked its streets and talked to locals to find out how the main issue in this year's campaign -- the country's financial woes -- is affecting people's lives and their votes.


text:
Invited to this game by Bilborough press officer Jevon Swinscoe. It was the first time Town have produced a League programme - and Jev was rightly pleased with his first attempt. Apparently all NSL games are to have a programme from this season onwards.
We are not avid followers of the NSL, but this game turned out to be quite enjoyable.....
A cracking setting, but facilities are a little on the sparse side, only one changing room for both teams and no cover for spectators - we were pleased that the rain that had threatened never materialised.
We knew a few of the Rolls players, but not many of the Town players were all unknown to us. I'd heard of John Manders, but can't remember seeing him play before, whilst keeper Alex Smith I remember from his Bulwell Town days.
The game kicked off a few minutes late - Rob Hornby's fault - taking a Bilborough Town team picture before the customary handshakes!
Rolls were ahead after just three minutes of play, a corner swept in from the right by Aaron Short was pushed onto the bar by keeper Smith. When the loose ball fell kindly to the feet of ASHLEY MARSHALL the left back gleefully prodded home from a few yards out.
Smith tries to see the ball over the bar
Marshall wheels away after prodding home the loose ball
The game was a bit scrappy, but Referee Barry Goodley wasn't helping things - missing challenges, punishing perfectly good tackles and generally "having a mare" !
Richard Harrison made a challenge - and gets a talking to!
Town were level on 22, TOMMY STREET controlling a ball that was hoofed high into the box, before sliding the ball past keeper Jake Pearson's and into the net.
Manders heads over
ANDY START put rolls back in front with a minute of the half left, bundling a Short far post free-kick past Smith. H-T 1-2
Start was gifted the ball by Smith on the hour mark, and the keeper tried to regain possession by fouling the Rolls striker on the corner of the box. Smith received a yellow, but as Start would probably have scored, he can think himself lucky he stayed on the pitch.
On 55, the visitors went further ahead when RORY SMITH volleyed home at the far post.
Smith did well to keep out a powerful Greg Conn shot with his legs on 75, but ANDY START beat the home keeper again on 88, finding himself unmarked in front of goal and firing wide of the keeper's despairing dive.
So, two minutes to go and Rolls comfortably ahead? Well, Mr. Goodley somehow found a good chunk of added time and the home team took full advantage, netting twice and leaving us thinking we will be playing until Town had equalised!!!
In the second added minute, MANDERS' cross/shot from the right caught the wind and flew over the outstretched arms of Pearson and into the far top corner.
STREET hammered a powerful shot from 15 yards past Pearson in the 95th minute, leaving a few squeaky bums in the Rolls' ranks. There were to be a further five minutes of constant home pressure before the Ref finally blew for full time. F-T 3-4
Programme £1 -- good quid's worth!
Attendance : head count 38 (Rob Hornby)


text:
26 Piper Drive, Red Deer
Fully finished 1730+ sq ft 2 Story Split Level, 4 Beds with 3 up, 1 down (with no closet) and 2 1/2 Baths plus main floor Laundry! This family friendly layout starts with an over-sized main entry for welcoming family and friends into a semi-open concept main living space that's bright with loads of natural light and into the Living room complete with bay window. The kitchen is nicely centered between the Family room and Dining room and has plenty of prep space, cabinets and counters and still has room for an eating bar. Down a few steps is the connected Family room that's perfect for family and entertaining with a brick faced, plus mantle, electric fire place for a cozy feel and garden doors out to a huge deck with awning and nicely cared for fully fenced back yard with mature trees. Upstairs are 2 good sized bedrooms plus the Master suite with room for a king, walk-in closet and 2pc en-suite. Head downstairs to the fully finished basement with dry bar and large L shaped games room, also perfect for entertaining, and lots of storage under 3rd level. This home is ready for your family with many improvements completed; new windows on the main, laminate flooring, vinyl flooring in the basement, new shingles in 2015 and a resurfaced front drive way.
Garage - Attached, Garage - Double
Den, Ensuite, Fireplace(s)/Woodstove(s), Laundry - Main Floor, Vinyl Windows, Walk-in Closet(s), Window Coverings - Other
Dishwasher - Built-In, Refrigerator - 1, Stove
Fence - Complete, Landscaped, Nearby - Park/Reserve, Nearby - Public Transportation, Nearby - Schools, Nearby - Shopping
RE/MAX real estate central alberta
The data included in this display is deemed reliable, but is not guaranteed to be accurate by the Central Alberta REALTORS® Association.
The real estate listing information and related content displayed on this site is provided exclusively for consumers. personal, non-commercial use and, may not be used for any purpose other than to identify prospective properties consumers may be interested in purchasing. This information and related content is deemed reliable but is not guaranteed accurate.


text:
Chanel Beauty Spring Summer 2014
Yesterday I went to see the new beauty collection from Chanel and there were so many musthave beauty products to make your spring pretty. Nail polish in colors like Tutti Frutti, Mirabella, Sweet Lilac, Eastern Light and Pink Tonic – your nails will be bright and colourful. I will shows you all of that when we get closer to sunshine. But in the meantime let me introduce you to one of the tools you can always find in my makeup purse. The lash curler. Chanel's is black and beautiful and makes your eyes look more open. Use for a few seconds before adding mascara and voilà.


text:
This document shows the step-by-step process to create a simple 'Blinking_LED' project. There is also a video which demonstrates the same steps. This project uses the S32K144EVB-Q100 EVB, connected to a PC through USB (OpenSDA) connection.
1. New S32DS Project
2. Provide a name for the project, for example 'Blinking_LED_S32DS'. The name must be entered with no space characters.
3. Expand Family S32K1xx, Select S32K144
4. Click Next
5. Click '…' button next to SDKs
6. Check box next to S32K144_SDK_gcc. It may be necessary to check the release notes for the SDK to confirm which version to select.
7. Click OK
8. Click Finish, wait for project generation wizard to complete
9. Notice Processor Expert views have opened.
10. Make sure Blinking_LED_S32DS is selected in Project Explorer view, then from the Components - Blinking_LED_S32DS view, select:
Components -> pinmux:PinSettings
11. From the Routing tab, select the GPIO pin routing group and scroll the list until PTD Pin 15 and Pin 16 are visible
12. On the row Pin 15, in the column Pin/Signal Selection set to PTD15, in the column Direction set to Output
13. On the row Pin 16, in the column Pin/Signal Selection set to PTD16, in the column Direction set to Output
14. Click Save
15. Project -> Generate Processor Expert Code
16. If not already open, In the project window double click the main.c file to open it.
17. Expand the clock_manager component in the Components Window
18. Drag and drop the CLOCK_SYS_Init function into main, after the comment 'Write your code here'
19. Drag and drop the CLOCK_SYS_UpdateConfiguration function into main
20. In the CLOCK_SYS_UpdateConfiguration add the following parameters.
Notice after the second parameter is added, it turns blue and when the mouse pointer is hovered over it the value is displayed. This shows it is recognized as a defined macro.
21. Expand the pin_mux component in the Components Window
22. Drag and drop the PINS_DRV_Init function into main, below the clock configuration
23. Expand the pin_mux:PinSettings component in the Components Window and add the following functions in sequence
24. Drag and drop the PINS_DRV_SetPinsDirection function into main immediately after PINS_DRV_Init
25. Drag and drop the PINS_DRV_SetPins function into main
26. Drag and drop the PINS_DRV_ClearPins function into main
27. For each of the PINS_DRV functions, there are 2 arguments, first is always PTD (which is macro defined in SDK), the second is defined as follows:
PINS_DRV_SetPinsDirection: OR-ing of LEDRGB_RED and LEDRGB_GREEN = 1 << 15U | 1 << 16U
PINS_DRV_SetPins: Bit shift of LEDRGB_RED = 1 << 15U
PINS_DRV_ClearPins: Bit shift of LEDRGB_GREEN = 1 << 16U
28. Include an infinite loop after these functions
29. Drag and drop the PINS_DRV_TogglePins function in to main, and place it inside the 'for' loop.
30. Again, the first argument will be PTD and the second is the same as for PINS_DRV_SetPinsDirection above.
31. Within the 'for' loop, and prior to the PINS_DRV_TogglePins function, add a delay of 720000 cycles
int cycles = 720000;
32. Build 'Blinking_LED_S32DS'. Select the project name in 'C/C++ Projects' view and then press 'Debug_RAM'
33. After the build completes, check that there are no errors.
34. Open Debug Configurations and select 'Blinking_LED_S32DS_Debug_RAM'
35. Check the Debugger settings and ensure that 'OpenSDA Embedded Debug - USB Port' is selected for interface.
36. Click Debug
37. Set breakpoint on PINS_DRV_TogglePins
38. Step through initialization calls
39. To see the output register bits change, go to 'EmbSys Registers' tab and expand 'GPIO', then 'PTD' and 'PDOR'. Double-click on PDOR to enable reading of the values.
40. Click resume to advance to the breakpoint, see the LED on board change color
41. Click resume again and see LED change to other color


text:
Easy Tips, Tricks And Advice For Working With Lawyers
June 16, 2013
It is never a good thing when you have to go to court, but there are things you can do to cut down on the stress. Choose a lawyer that fits your needs. Keep reading for some great advice on how to get the best lawyer to assist you.
Get a list from every lawyer you interview.The charges can vary widely depending on the lawyer's experience and skill; therefore, and it is smart to be aware of what you are going to pay before you retain him. It would be a shame to lose your lawyer after your case has already underway.
You want to always be able to easily get in contact with your lawyer. Having issues with reaching a lawyer that a common issue. You shouldn't get stuck wondering what's going on with your hair if you have a lawyer that's on vacation.
You might think about paying a lawyer a retainer just to be on the safe side. This will allow you from rushing to look for one in the case of an emergency. A retained lawyer will also be able to answer any way.
You shouldn't just want to choose the first lawyer you find. You should do the proper research in order to get the best decision. You may even find out that you choose the wrong lawyer and end up losing your case.
You need to touch base with your lawyer about the best time for you to work together. Many lawyers get paid and go without client contact for long time. You can avoid this if you come up with a schedule at the outset.
Ask your friends and acquaintances for advice.This can help you save both money and also take the work off of you.
Companies who work with legal professionals are going to be able to help you locate good resource for referrals. For instance, if you're into small business law, you should speak with a banker, banker, an accountant, and the like. These people constantly interact with lawyers a lot and may give a more informed opinion.
Before you hire any attorney, contact your local bar association to ensure no complaints have been filed against the attorney. If they have some, research them to see whether you should consider hiring a different attorney.
As mentioned before, getting the best lawyer can really affect your fortunes if court dates are on the horizon. Don't choose someone because they're the cheapest, find someone who will perform the task. Keep these tips in mind when you are looking for a lawyer.
This information served as a great tutorial regarding virginia divorce laws, how to divorce, divorce in wisconsin. This article definitely has the wisdom that you seek. All you need to do now is put it into action.


text:
Product Description
Men's Trending Series watch featuring a black resin band and case with blue accents and front button Super Illuminator light. Black face with LED light with afterglow, world time display, and hand shift feature (hands move out of the way to provide an unobstructed view). 5 daily alarms, hourly time signal, and stopwatch capacity. Countdown timer, full auto calendar, and 12/24-hour format. Shock resistant and water resistant up to 200 meters.


text:
Sweden's Robin Olsen pulls off super save in goalless draw with Russia
Sweden goalkeeper Robin Olsen pulled off a world-class save as his side held Russia to a 0-0 draw in their Nations League B, Group 2 clash in Kaliningrad on Thursday.
Both teams exited this year's World Cup at the quarterfinal stage and Sweden once again showcased the defensive stability that has made them so hard to beat under coach Janne Andersson.
The hosts failed to convert their dominance of possession into shots on target until 10 minutes from full-time, when Olsen had to make a superb, acrobatic save to keep out a fearsome effort from Daler Kuzyaev.
That was the closest either side came to breaking the deadlock and the result leaves Russia top of the group on four points after two games.
Russia face second-placed Turkey, who are a point adrift, on Sunday, with the Swedes bottom on one point ahead of their friendly with Slovakia on Tuesday.
Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.


text:
But oh man, this ain't baseball…
I've been having a really rough week and to top it all off, I couldn't finish my long run yesterday. I wasn't feeling too great physically or mentally, and afterward I broke down a little bit. I've just been super frustrated with myself, and not being able to finish a workout that would have felt easy last week was just the icing on the cake.
I'm not even going to bother with a weekly recap today. My mileage this week was a whopping 8.58 miles, and I think that sums up this week pretty well.
I'm not writing this post for attention or sympathy, or to feel sorry for myself. I'm actually feeling pretty optimistic. This week is done and over with, and it is what it is. Tomorrow starts a brand new week, full of new opportunities.
I'm writing this because I don't think enough people talk about the bad days, weeks, or months. It's really easy to talk about your good runs, high milage weeks, PRs, and good races. And that's great! Celebrate your accomplishments, big or small! But don't pretend it didn't take blood, sweat, and tears to get there.
Let's face it; our sport isn't always a pretty one. It can't always be sunshine, rainbows, new shoes, good food, and PRs, ya know? But scrolling through Instagram, twitter, and a lot of blogs it can sure seem that way sometimes, and I think that can get a little bit discouraging. Especially when you're having a rough go at things.
So I'm here to tell you it's ok to cry! Fucking curse if you need to! Take a day off or cut a run short if you have to. Yell at your husband because he isn't being sympathetic after a really bad run…well, at least apologized afterwards. 😆😉 It's ok to not be in love with every second of running. Sometimes running really fucking sucks.
The words "relentless forward motion" are at the very top of my blog for a reason; as long as you're still putting one foot in front of the other you'll eventually get to where your going. Even if you stumble a little (or a lot). I promise.


text:
Amelie Halo
Scrolling leaves with sprays of dainty off white flowers with crystal centres adorn this feminine halo
- Made of brass vines of leaves and flowers
- Hand soldered together
- Ribbon ties at either end
- Crystal flower centres
- Handmade in our Auckland, New Zealand studio
- This item is "Made to Order" with the creation time of 2-3 weeks plus shipping times
- Rush processing times are often available if needed. Please message me with the style name, colour, and wear date and your location for further information and associated fees.
Follow the link to view our other items https://www.etsy.com/shop/AnnaMarguerite
Photography- Captured by Keryn
This crown is an absolute favorite! Made of beautifully detailed leaves and pretty flower accents, this crown is perfect for a stylish bohemian bride or an ethereal garden wedding. - Adorned section is 11 inches long by 2 inches at...
Made of over a hundred organically shaped leaves this tiara creates a timeless and stylish statement. This tiara is always a favorite and is our best seller! - Adorned section is 11 inches long by 2 inches at its widest...
Hundreds of hand shaped myrtle leaves curl and reflect the light in this romantic and organic piece. Inspired by antique myrtle tiaras of the late 1800s- early 1900s this tiara references the past and creates a memorable and chic statement....
This delicate and airy tiara made of sprigs of metallic leaves draws from the Grecian era to create a subtle ethereal statement. - Adorned section is 11.5 inches long by 1.5 inches at its widest part (29cm x 4cm)- Features...


text:
I've been thinking lately about why I have such strong left-leaning sentiments, and why I get so annoyed by the unthinking conservatism of others I see around me. And the best explanation I can come up with is this: I have enough imagination and enough empathy to realise how damn lucky I am. I was born at the right time, born in the right place, born to good people, and blessed by knowing so many other good people throughout my lifetime. I don't have a perfect life, but the life I have is a damn good one, and it could easily have been so much worse.
So, a song which has been reminding me of this lately:
"All God's Beggars" by Kavisha Mazzella [1]. Taken from her album "Silver Hook Tango".
This is the song which has been spamming my mental playlist. The lyrics are below the fold.
( All God's Beggars - lyrics by Arnold Zable and Kavisha Mazzella )
Ms Mazzella is a second generation child of immigrants (rather like my own parents... of course, my three immigrant grandparents were all immigrants from England) and she rather neatly skewers the attitude I loathe so much about the notions of so many overly-vocal Australians toward those persons who want to emigrate to this country now. I was born in this country. I'm lucky. Call me superstitious, but I don't want to try and deny anyone else the chance to grab a piece of this luck themselves, because that may kill the luck altogether.
[1]Link leads to sendspace, feel free to grab the song if you want it. If you like it, you might want to consider buying her albums - her website is Kavisha Mazzella.
This entry was originally posted at http://megpie71.dreamwidth.org/6749.html. Please comment there using OpenID.


text:
Finish your festive feast with a show-stopping mango cake based on everyones favourite tropical cocktail - the pina colada.
The ingredient of Mango colada fridge cake
- 250g mascarpone
- 1/4 cup (55g) caster sugar
- 2 tablespoons lime juice
- 1 1/2 cups (375ml) thickened cream
- 1/2 cup (125ml) passionfruit pulp, strained
- 1/4 cup (60ml) Malibu coconut rum (optional u2013 see tip)
- 1/4 cup (60ml) pineapple juice
- 12 savoiardi sponge finger biscuits
- 1 mango, peeled, coarsely chopped
- 120g fresh raspberries
- 1 mango, extra, thinly sliced, to serve
- Passionfruit pulp, extra, to serve
- Mint leaves, to serve
The instruction how to make Mango colada fridge cake
- Line the base and sides of a 7cm-deep, 9cm x 21cm straight-sided loaf pan with plastic wrap, allowing sides to overhang.
- Place mascarpone, sugar, lime juice, half the cream and half the passionfruit pulp in a large bowl. Whisk until well combined and mixture thickens slightly.
- Combine rum, pineapple juice and remaining passionfruit pulp in a shallow bowl. Dip 1 biscuit in the rum mixture and turn to coat. Place in the prepared pan. Repeat with rum mixture and 3 of the remaining biscuits. Spoon over half of the mascarpone mixture and top with half the chopped mango and raspberries.
- Repeat with the rum mixture, 4 of the remaining biscuits, remaining mascarpone mixture and remaining chopped mango and raspberries. Soak remaining biscuits in the remaining rum mixture. Arrange over the top. Cover with plastic wrap and place in the fridge for 6 hours to set.
- Carefully turn the cake onto a serving platter and remove plastic wrap. Use a small palette knife to smooth the sides.
- Use an electric mixer to whisk the remaining cream in a bowl until firm peaks form. Spoon over the top of the cake. Arrange the sliced mango on top. Drizzle with extra passionfruit pulp and sprinkle with mint leaves to serve.
Nutritions of Mango colada fridge cakecalories: 346.55 calories
calories: 24 grams fat
calories: 16 grams saturated fat
calories: 27 grams carbohydrates
calories: 4 grams protein
calories: https://schema.org
calories: NutritionInformation


text:
The latest outpost in Myanmar of one of the largest international law firms was born out of a sense of adventure and despite being small in size, Baker & McKenzie has big plans, managing partner Christopher Hughes said.
"This is a country in transition and there is optimism that follows that," Mr. Hugh's told The Myanmar Times from the firm's recently opened offices in Yangon.
"I don't think there are too many places like [Myanmar] right now. From a lawyer's point of view, there are very significant reform efforts going on," he said.
Mr Hughes was made partner in the Sydney office three and a half years ago and began turning his mind to where his next venture would lie.
"Australia is a long way away from a lot of places," he said. "One of the drivers for me doing law was to have international experience … I'd always wanted to spend more time living up here.
"The law reform agenda is ambitious and it is going to take a little while to completely fill in the regulatory framework. Lots of good primary legislation and detail and implementation of that will follow," Mr Hughes said. "With an agenda of that size, obviously there is a bit of bandwidth issue. So much is happening and so much happening at once. The logic of the change is very good, but it will take a bit of time."
The office currently has two foreign lawyers, including Mr Hughes, and five Myanmar lawyers who are focusing on the firm's intellectual property practice and a commercial and corporate advisory practice mainly working for regional multinationals looking to enter the Myanmar market, he said.
"[The advisory work] is something we can do for our clients, explain the dynamics of what it's like to work here," he said. "Some of the doing business indexes and transparency indexes and so on have come out and shown Myanmar is moving in the right direction but it is also at the lower end of those indexes, so while the raw materials and opportunities here are great, the ease of doing business is still a little difficult and part of that is driven by unfamiliarity.
"People are naturally worried whenever they invest in new jurisdictions around compliance and doing business issues there," he said, adding that navigating the legal framework and currently financial system of the country were often cause for pause among foreign investors.
"The reform agenda of the government, particularly in the area of improving and modernising the commercial laws that are going to drive investment here, is very positive," he said, adding that he expected the volume of business to increase dramatically once important infrastructure and legislation was in place.
source: The Myanmar Times


text:
The Bianconeri jerseys will be on the fields of the "fourth category" a football tournament dedicated exclusively to children with cognitive and relational disabilities.
Created on January 18, thanks to the Memorandum of Understanding between Centro Sportivo Italiano and FIGC and the collaboration of AIAC, AIA, AIC, League A, Lega Serie B, Lega Pro, Lnd, Figc and Csi, "Fourth category" can lead forward their message of social integration through pairing teams involved in the project and big clubs in Italy. A partnership with Juventus has been created with the team Pinerolo FD which will provide the technical instruction and the famous black and white kit.
This morning, the presentation of the second edition of the tournament, held at Bettinelli Sport Center of Milan, saw Gianluca Pessotto deliver the uniforms to Pinerolo, who now take the field with the Bianconeri colors and will be named Juventus Special: "It's extraordinary to see how much passion and emotion these guys live in sport," said Pessotto. "We are happy to have joined this project, to have adopted Pinerolo FD and to help the kids to demonstrate what really makes them special."


text:
Ornah Levine-Dolberg, MD
Dr. Ornah Levine-Dolberg graduated from the Ben Gurion University, Medical School in 1990. Following her residency in Psychiatry completed cum laude, she was the Director of the Day Hospital at the Sheeba Medical Center in Israel for 7 years. Her first industry role was in 2003 as a Country Medical Director for Lundbeck. After 3 years in that role she moved to Copenhagen to take up various roles in Global Medical Affairs, including heading the department of Scientific Communications, responsibility for a competitive ISS program, and being the Global Medical Director for escitalopram, a highly successful treatment for Mood and Anxiety Disorders. One of her final roles in Lundbeck was the launch of escitalopram in China.
Dr Ornah Levine-Dolberg joined Teva Pharmaceuticals in mid-2013 to head the newly formed Medical Affairs, Growth Markets. From a team of 2 this department has grown to more than 100 employees. Dr Levine-Dolberg established all functions in this team including Medical Operations and Excellence, Therapeutic Area Leads and their operating model, Country Medical Directors and their departmental structures and deliverables. On a regional level, she built various infrastructure capabilities such as Medical Information, promotional material review, governance bodies, operating models, KPIs, financial structures, and a strategic project called Signature Medical Moves. In addition, Ornah was part of the leadership team of Growth Markets and a prominent member of the Global Medical Affairs Leadership team.
In September 2016 Ornah joined Glenmark Pharmaceuticals in their London headquarters to establish and launch Global Medical Affairs and to help the company in its transition from a medium sized Indian company to a global presence with expertise in all facets of drug development and commercialization.
Danie du Plessis, MD, MBA
Danie is a senior pharmaceutical executive with 25 years' experience mainly in medical affairs. He has a passion for modernising medical affairs and track record in leadership, people development, capability building and coaching. Danie is a qualified MD with a Masters in Clinical Pharmacology who combines medical and life science qualifications with an MBA. Danie has extensive experience building international teams, driving change and working in regulated markets for GlaxoSmithKline (GSK) across Europe, the Americas, Middle East, Africa, Australasia and Japan.
He previously worked for Eli Lilly & Company for 17 years in different medical roles as well as marketing and sales. During his different roles, he was based in South Africa, United Kingdom and Australia. Before joining the Pharmaceutical Industry, Danie had his own primary care practice. Danie started his own mentoring, coaching and consulting business, TheNextVersion Ltd, in Jul 2018.
Iris Loew-Friedrich, Prof. Dr. med
Prof. Dr. med. Iris Loew-Friedrich is Chief Medical Officer for UCB, a member of the company's Executive Committee and Head of the Development & Medical Practices. She provides strategic global leadership for world-wide clinical development, medical affairs, regulatory affairs, real world evidence, patient safety/pharmacovigilance and external engagement. Iris started her service for patients in the pharmaceutical industry in 1992 with a focus on clinical development in the areas of immunology, bone disease and neurology, delivering together with her teams several novel medicines to patients. She held various positions in Research and Development in different companies, always with a focus on global drug development. Since 2001, prior to joining UCB, Iris was the Global Head of Research and Development at Schwarz Pharma (acquired by UCB in 2006) and a member of their Executive Committee. Iris is a physician, board-certified in internal medicine, with a medical license from the University of Frankfurt where she also holds a visiting professorship at the Medical School. Iris is active in industry associations, a member of different supervisory boards, including the board of TransCelerate. She is passionate about making a difference to the lives of people living with severe diseases.
Michael Zaiac, MD
Following Graduation in Medicine at the Free University Berlin, Michael pursued a career in General, Cardiovascular and Surgical Oncology gaining an MD and an FRCS. He joined pharmaceutical industry 24 years ago and has since been in clinical development, project leadership, and commercial and medical affairs roles at country, regional and global level. Throughout his clinical and industry career, Michael mainly covered specialty care areas, e.g. Oncology and Immunology. He also qualified as a Pharmaceutical Physician and as an MBA. Research interest and publications are in Oncology and Immunology as well as in general aspects concerning Medical and Clinical Affairs in the Industry
Baris Ugur, MD, PhD
Dr. Baris Ugur is currently Head of Medical Affairs Turkey & Israel at Sanofi Pasteur. He has worked in various therapeutic areas and companies including national and international medical affairs positions (Pfizer / Emerging Markets Europe). He has studied medicine and involved in Public Health doctorate program at Istanbul University. He has an ongoing PhD in Clinical Psychology. He also holds a diploma in business administration.
Mark Rees-Saunders
Extensive and diverse experience in the Pharmaceutical and Healthcare Industry, including R&D, Sales, Sales Training and Medical Affairs. The last 17 years have been in Medical Affairs, predominantly involved in the set up and leadership of field based medical (MSL) teams, after an initial 6 years as an active MSL. As a first line manager developed and implemented an MSL function across a strategic alliance and as a second line manager reorganised the MSL function at AstraZeneca UK, including the successful development of an MSL Excellence scorecard to assess and develop operational MSL Excellence. Extensive stakeholder management experience, at a National, European and Global level, involving medical strategy development and the development of core MSL skills, capabilities and performance assessment.
Charlotte Kremer, MD, MBA
Charlotte M. E. Kremer, MD, MBA is the Executive VP and head of Medical Affairs for Astellas. In this role, Dr. Kremer provides leadership for the Medical Affairs organization globally.
Dr. Kremer joined Astellas in 2012 with 20 years of experience in the pharmaceutical industry. Prior to Astellas, she held the position of Vice President, Therapeutic Area Head for Ophthalmology, PVD, Rare Diseases and Neuroscience at Pfizer. While at Pfizer, she successfully led and executed the clinical development and global medical programs in these respective areas. Prior to joining Pfizer, Dr. Kremer held positions of increasing responsibility providing medical support, developing Phase 3b/4 clinical trials, and initiating and directing a Medical Liaison program at Organon Pharmaceuticals, both in the Netherlands and in the United States. A native of the Netherlands, Dr. Kremer received her medical degree from the University of Utrecht, The Netherlands. She went on to receive her Diploma Pharmaceutical Medicine (DPM) from Universite Libre de Bruxelles. After transferring to the United States, Dr. Kremer completed the Executive MBA program at New York University's Leonard N. Stern School of Business.
Mikhail Sumin, MD, PhD
Dr. Mikhail Sumin has 8 years of experience in Academic Medical Science and 12 years of working in pharmaceutical industry. He started a career from Clinical operations department of Parexel international and after 6 years he moved to Medical Affairs of Boehringer Ingelheim. Currently Dr. Sumin is a Head of therapeutic area cardiovascular at Medical Affairs of Boehringer Ingelheim Russia. During his professional pathway he has been working within various therapeutic areas such as cardiovascular, metabolism, oncology/hematology and rheumatology. Professional interests and experience of Dr. Sumin are related to development and execution of medical communication strategy, field-based medical affairs functions, generation and using real world evidences, Investigator-initiated studies.
Kirk Shepard, MD
Dr. Kirk Shepard is the 2016-2017 President of the Medical Affairs Professional Society and has more than 25 years of experience in the pharmaceutical industry. He is a board-certified medical oncologist and hematologist physician. He is currently Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Pharmaceutical Company.
Dr. Shepard's experience in multiple therapeutic areas includes operational and strategic product development from Phases I through IV and the diverse disciplines of medical affairs and product commercialization, such as leading compliance and SOP/policy efforts, health economics & outcomes research & patient access, data generation, field-based medical teams (MSLs), PV/safety, medical communication & publications, patient advocacy, and public relations. In 2015, he was selected as one of the 100 Most Inspiring People in the Pharmaceutical Industry (PharmaVOICE).
Before his pharmaceutical career, Dr. Shepard served as a staff physician in the Department of Hematology and Medical Oncology at the Cleveland Clinic Foundation, where he supervised numerous studies in oncology and symptom control. He has more than 50 medical publications in journals and books. Dr. Shepard earned his bachelor's degree from Cornell University in Ithaca, NY, and his medical degree from the University of Cincinnati Medical School in Cincinnati, OH. He completed both his internship and residency in internal medicine at Case Western Reserve University in Cleveland, OH, and fellowships in hematology and oncology at the University of Chicago Hospitals and Clinics in Chicago, IL.
William Mwiti, MD
Rick Morton, BSc(Hons), PhD
Dr. Rick Morton currently the Chief Medical Affairs Officer at WPP Health & Wellness (London & New York) and prior to this position was the Associate Vice President and Head of Value & Access at Allergan, based in the Allergan International Office in Marlow, UK. He received a doctorate in Neuropharmacology from the University of Manchester, UK and has a B.Sc (Hons) degree in Pharmacology from the University of Liverpool, UK. Rick has extensive academic, biopharmaceutical industry and global healthcare consulting experience, across a diverse therapeutic range, notably, neurosciences, ophthalmology, rheumatology, urology, gastroenterology and immunology.
Rick has previously been head of function in Allergan's Medical Affairs and HEPRA for the EAME region and prior and to this worked in Switzerland for Novartis Pharma as a Global Access Lead on early pipeline development assets. He has also extensive drug development and commercialization experience from working as Vice President, Consulting at PAREXEL in addition to a previous role as MD of the Global Market Access consultancy, WG Consulting. Rick has also extensive biopharmaceutical industry experience with G.D Searle, Pfizer and Yamanouchi, and prior to this was in academia as a lecturer in Pharmacology and Physiology at Wolverhampton University, UK. Rick is passionate about the critical role of medical affairs in the planning and execution of pre, peri and post launch patient and market access strategies that guide effective healthcare product development and commercialization.
Mathieu Boudes, PhD
Mathieu Boudes, PhD, joined the European Patients' Forum (EPF) in 2018 as coordinator of the PARADIGM project, a public-private partnership financed by the Innovative Medicines Initiative and co-led by EPF and EFPIA (European Federation of Pharmaceutical Industries and Associations).
Strong of 34 partners (patient organisations, pharmaceutical / biotech companies, regulators, HTA bodies and academic teams), PARADIGM (for Patients Active in Research and Dialogues for an Improved Generation of Medicines) will strengthen the understanding of stakeholders' needs, the systems-readiness, ensure maximum synergies with other initiatives and develop an inventive and workable sustainability roadmap.
Previously, Mathieu worked for EURORDIS-Rare Diseases Europe since 2013. Mathieu was involved in activities to foster the access to innovation to patients.
Robin L. Winter-Sperry, MD
Dr. Robin Winter-Sperry started working in the industry in the area of Dermatology. She has had a long and distinguished career including Sanofi/Genzyme Global Medical Affairs, Strategy & Tactics in the area of Multiple Sclerosis and President and CEO of Scientific Advantage, LLC. She created Novartis' Medical Science Liaison (MSL) department of Scientific Operations and Sanofi-Synthelabo's Medical Therapeutic Liaison division.
She has been involved in over 28 product launches. She has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry's leading Medical Affairs and Medical Liaison teams.
Alexandra Safronova, MD
Alexandra Safronova, MD is currently Medical Director and Head of Medical Affairs at Boehringer-Ingelheim, Russia.
Dr. Safronova earned her medical degree from Moscow Medical Academy cum laude. She completed her residency in internal medicine at Moscow Medical Academy, and fellowships in intensive care at Pirogov Medical University and endocrinology at the Russian Medical Postgraduate Academy.
Before her pharmaceutical career, Dr. Safronova served as a staff physician in the Cardiology and Intensive Care Department at Medical Center of the Russian Academy of Science.
Dr. Safronova started her career in the pharmaceutical industry in 1999 as Clinical Research Scientist at GlaxoSmithKline, then she worked as Manager of Clinical Operations at Quintiles (now IQVIA).
In 2010 she joined Teva as Director of Clinical Research. Her primary task there was to set up Clinical Research Department from the scratch to support registration of new products and supervise global studies. Within two years Teva became #1 in clinical research in Russia. The company received 7 new market authorizations supported by the results of clinical program developed and executed by the department headed by Dr. Safronova. In 2013 Dr Safonova focused on building Medical Affairs function as Medical Director of Russia and CIS, Teva Pharmaceutical.
Dr. Safronova's experience in multiple therapeutic areas includes Phases I-IV and diverse disciplines of medical affairs and product commercialization, such as leading office based and field-based medical teams (MSLs), PV/safety, Regulatory Affairs, Medical information, Patient Advocacy.
Peter Rutherford, MB BS, PhD, FRCP
Peter Rutherford is Global Medical Lead for Renal Rare Disease at Vifor Pharma in Zurich, CH. He qualified in Medicine at the University of Newcastle upon Tyne, UK and completed postgraduate medical training to obtain MRCP in 1989. He entered an academic training pathway in Nephrology with an MRC Training Fellowship allowing him to complete a PhD in cell physiology as well as completing clinical training in Nephrology and Internal Medicine. He was then an MRC Travelling Fellow at Yale University School of Medicine gaining additional academic experience in molecular biology.
After return to the UK as Lecturer in Medicine at the Unversity of Newcastle, he was appointed as Senior Lecturer in Nephrology at the University of Wales College of Medicine and Consultant Nephrologist. In this role, he combined clinical practice in delivering a full range of nephrology services with academic work. Peter then developed expertise as a clinical leader in the hospital and became the Medical Director of a combined acute, community and mental health NHS organization leading on patient safety, clinical effectiveness, service improvement and research. In addition he was a Clinical advisor at NICE and chaired their Guidelines Review Panel until he joined Pharma in 2007.
From 2007 to 2015 he was Medical Director Renal for Europe, Middle East and Africa at Baxter Healthcare – being responsible for all aspects of Medical Affairs activities across the region. He worked on research projects in patient support, decision making and education as well as new product development for home dialysis. From 2015 to 2017 he was Head of Integrated Market Access at Quintiles in Europe and Emerging Markets – supporting small and large Pharma and emerging biotech companies with medical affairs, medical communications, market access and patient centric services. Focused on launch brands, Peter support a range of companies across a range of therapeutic areas. Since joining Vifor Pharma, he is back on home ground in Nephrology but working in systemic diseases affecting every organ system.
Alexander Semenov, MD
Dr. Alexander Semenov received his medical degree from Lviv National Medical University, Ukraine, where he also pursued specialty training in General Surgery, completed it cum laude and worked in regional hospital a couple of years. Next to medical degree Alexander is certified in Marketing by Edinburgh Business School of Heriot-Watt University.
Alexander started his professional pathway in pharmaceutical industry 16 years ago in Pfizer (in 2002). The last 15 years he devoted to Teva and its affiliates, where he had various leading positions in different functions – Sales and Marketing, Portfolio and Business Development, Quality Assurance, Regulatory Affairs and since 2010 he has been holding the Country Medical Director position in Ukraine.
Besides this Alexander is the member of Medical Affairs Leadership Team in the region "International Markets" that embraces LATAM, EMIA and APAC. On the regional level Alexander acts as the Senior Regional Medical Director and is responsible for providing medical governance and medical support for branded generics.
Maria Sanzharovskaya MD, PhD
Dr. Maria Sanzharovskaya, MD, PhD has 12 years' experience in Pulmonology and Clininal Allergology working in clininc and on the chair of Internal Medicine performing scientific and educational work. During this period 53 papers were published in COPD area, presentations during European Respiratory Congresses several times were sponsored by European Respiratory Society. Participated in more than 20 clinical trials in respiratory area as investigator. Maria made Research Fellowship in Instituto Hospital del Mar de Investigaciones Médicas in Barcelona in muscle disfunction hypercapnia.
She started her pharma career at Boehringer-Ingelheim as a Medical Advisor responsible in the respiratory area.
After 2.5 years Dr. Sanzharovskaya moved to Vienna where she was responsible for scientific support in the respiratory area for 18 countr
Giota Papamarkou
Giota is a senior professional with over eleven years of experience in Ethics & Compliance and Internal Controls in multinational pharmaceutical companies.
In March 2015, Giota joined Ipsen and since then she has been responsible for the development and enhancement of the Global Internal Ethics & Compliance Program and she has been the Ethics & Compliance Officer for the Global Teams reporting to the Ipsen's Chief Ethics & Compliance Officer. In February 2016, in addition to her global responsibilities, Giota also took over the oversight of the Ipsen China Ethics & Compliance Program's evolution and in January 2018, France has been added under her oversight.
Previously, Giota was Country Compliance & Ethics Officer for various European countries and Contributor to the European Compliance & Ethics Program in Bristol-Myers Squibb based in Paris and Athens and earlier, she held various positions in Business Controls in the same company based in Athens.
She received a university degree on Management Science & Technology from the Athens University of Economics and Business and completed the Sciences Po European Healthcare Compliance, Ethics and Regulation Programme and the Insead Healthcare Compliance Implementation Leadership Programme – Part II.
Giota speaks Greek, English and French and she is member of the ETHICS Association.
Jorge Fragoso, MS
Jorge´s current role is Global Head of Vaccines Field Medical Program in Sanofi Pasteur. In this function he is in charge of coordinating several initiatives related with Medical Science Liaison team.
Jorge was born in Mexico City, and graduated from the National University of Mexico. He is a Biologist and holds a master's degree with honors in Neurosciences.
Jorge joined Sanofi in 1991 and he drives his knowledge in Sales, Marketing, Business Support, e-business, training and Medical through more than 25 years of experience holding various roles in Pharma Mexico. Jorge joined the Latin America region team in 2010 and, since 2015, he has been coordinating several important initiatives at a Global level in Sanofi Pasteur. Those multidisciplinary functions provide to Jorge an interesting transversal view of the Pharma environment.
When not traveling to train teams, Jorge enjoys writing science fiction short stories and reading. He also loves savoring food of the world (his biggest challenge: a crunchy and spicy scorpion in a Beijing market!)
Mónica de Abadal, MD, MBA
Dr Mónica de Abadal is an Executive Leadership Committee Member of the Medical Affairs Professional Society EMEA with more than 16 years of experience in the pharmaceutical industry
Dr de Abadal has experience in multiple therapeutic areas, including oncology, endocrinology and movement disorders as well as operational and strategic Medical Affairs experience in diverse disciplines of medical affairs and product commercialization, such as leading compliance and SOP/policy efforts, quality management systems, data generation, field-based medical teams (MSLs), safety, medical communication & publications
She has served as a board member in companies specialized in telemedicine and has international Medical Affairs experience in Europe, APAC (Australia) and global positions, including deputy Chief Medical Officer, Global Head of Publications. She currently holds the VP Global Medical Affairs Services group position at Ipsen.
Dr de Abadal obtained her medical degree from the University of Barcelona and entered residency in Anaesthesiology in Hospital Vall d´Hebron (Barcelona) ). She validated her medical degree in the US (USMLE) and obtained an MBA specialized in Healthcare administration from (USF) and a postgraduate diploma in Pharmaceutical Medicine (UAB).
She feels passionate about Medical Excellence.
Malcolm Barratt-Johnson, MD
Malcolm is Managing Director, of PharmaMedic Consultancy Ltd a London based International biosciences consultancy company, and Immediate Past President of the Section of Pharmaceutical Medicine and Research of The Royal Society of Medicine, London, UK.
With over 20 years experience as a Consultant Pharmaceutical Physician to Industry and Government, Malcolm advises bioscience and pharmaceutical companies on Product Development, Regulatory Strategy and Medical Affairs, focusing on Start-Ups and SMEs. He acts as a Clinical Specialist and Chair to the European Commission's Biomedical Research Programme (Horizon 2020), lectures in both Europe and the United States on medicinal development, and teaches on the Pharmaceutical Medicine and Regulatory MSc Course of Copenhagen University.
Following a first degree in Physiology at King's College London, Malcolm qualified in medicine from St Bartholomew's Hospital, in 1993. After postgraduate training in General and Intensive Care Medicine he joined the UK Government as a Medical Assessor in new medicines in 1997. After senior industry roles at Pfizer and AstraZeneca he re-joined Government as Lead Medical Assessor to the UK Dept of Health's Clinical Trials Unit on it's formation in 2005, and worked with the European Medicines Agency (EMA) on the development of a trans-European clinical development process in the pharma and biotech sectors. Leaving full time employment with the Government in February 2007, Malcolm was appointed as an Independent Consultant to the Dept of Health.
He has worked extensively in senior UK and Global consultancy positions with most of the top ten pharma companies including AstraZeneca, Eisai, Roche, Novartis, Schering-Plough / MSD and GSK, in addition to having advisory development roles in the biotech, device and generic pharma sectors.
In 2012 he was appointed President to the Section of Pharmaceutical Medicine and Research at the Royal Society of Medicine, London and in 2014, a Fellow of The Royal Society of Biology.
Matthew Bending, PhD, MSc., BSc. Econ
Dr. Bending is a Health economist with a PhD in Health Sciences studying the use of HTA in reimbursement decision-making with over 13 years (>100 HEOR/MA projects) consulting experience. He is Head of the HTA, Strategy and Communication team and Senior Director at ICON.
Dr. Bending developed early HTA and payer engagement services in ICON and has experience of more than 40 formal integrated HTA scientific advice engagements across a range of disease areas. He completed a PhD fellowship on the use of Health Economic Analysis in OECD countries' pharmaceutical systems and its contribution to decision-making. He has presented at international conferences and published over 30 reports/papers and been involved in more than 100 HEOR and market access consulting projects. Dr. Bending was a co-author of a study that won the Egon Jonsson award in 2009/2010 for most outstanding paper published in the International Journal of Technology Assessment in Health Care on the harmonization of HTA across countries.
Dr. Bending provides senior leadership for large projects on strategic market access and Health Technology Assessments (HTAs) for pharmaceutical, vaccine, and medical device companies. His experience is wide-ranging, from projects for international HTA submissions, HTA scientific advice, value proposition development, market access, systematic literature reviews, health economic models, payer advisory boards, and global value dossiers.
Prior to joining ICON, Dr. Bending was a Senior Consultant at York Health Economics Consortium, working on projects for the National Institute for Health and Care Excellence, Department of Health, Patient Safety Research Portfolio, General Medical Council and more. Dr. Bending has a PhD in Health Sciences from the University of York and his thesis explored the use of HTA in international reimbursement decision-making. He also has an MSc and BSc honours in Economics from the University of Warwick.
Gwen Wiseman, Bsc, Hons
Alex Butler, FCIM
Alex is one of the world's leading experts at the intersection of health and technology.
Working in the pharmaceutical industry for 20 years, for the last 15 years he has lead the digital transformation of healthcare, both from within the industry at Johnson & Johnson and servicing the industry by founding and leading multiple award-winning agencies. Most recently he co-founded Foundry3 which houses the world's first digital health innovation Lab focused on the pharmaceutical industry, the 'Innovation Foundry'.
Alex pioneered the application and integration of new philosophies and technologies within pharma, launching the first digital only marketing campaign supporting a pharmaceutical brand, he was the first to utilize social media and he commissioned and designed mobile health applications before the advent of the app store.
This led to numerous digital marketing and communications awards, the inaugural recipient of the Global Social Media Pioneer award in Philadelphia in 2010 followed by the James E Burke Marketing Award for Uncommon Courage in 2011, the first pharma professional recipient. He has won over 30 PM Digital awards and the prestigious AXA PPP Global Health Technology Award 2017 with his work displayed in the Design Museum in London.
Alex has been the brain child of ground breaking digital health solutions in respiratory disease, Pulmonary Arterial Hypertension, transplantation, opioid addiction, MS, diabetes and psoriasis among others.
He is also an invited member of the Wharton Global Advisory Board on the Future of Advertising and a Fellow of the Chartered Institute of Marketing (FCIM).
Amanda Sweeney
As Senior Vice President, Client Success, Amanda is Within3's utmost client advocate. She leads the team that is accountable for guiding clients through the process of defining their program objectives and expectations, aligning Within3's online discussion platforms to exceed client performance outcomes, and championing the client-centric culture that consistently results in delivering meaningful, measurable results.
Amanda began her career in 1997 in the world of computer hardware product management and procurement. In 2004, she shifted gears and applied her management skills to client services, in the arena of medical communications, with an emphasis on digital solutions.
Amanda has held product management and procurement roles at Intel Corporation and Micro-Star International and leadership roles in client services for Healthcare Consultancy Group (Omnicom) and PSL Group.
Her intuition, proactive nature, and attention to detail, have fostered lasting relationships with her clients. She listens closely and puts herself in the client's shoes, in order, to be consultative and provide direction that will ultimately result in the achievement of their program goals and objectives.
Over the course of her tenure, Amanda's strength has always been client-focused. Her dedication, passion, and commitment to client service has been the forefront throughout her career.
Erik Briers, PhD
Erik Briers holds a doctorate in Chemistry (1979) from the University of Leuven, Belgium. After teaching chemistry and physics, Briers served from 1979 until 1980 as the Head of the department for biochemistry, at the Central Medical Laboratory in Antwerp, Belgium.
From 1980 to 1982 Briers worked as Head of scientific services for bioMérieux in the BENELUX. In 1982 Briers founded a biotech company ECO-BIO. ECO-BIO was an in vitro diagnostics company specialised in microbiology and immunology. One of the products for the detection of Aspergillus antigens (galactomannan) Dr Briers developed has FDA approval.
Since 1990 Briers is CEO of Beta Ventures, consulting the in vitro diagnostics industry and publisher of specialised media on laboratory medicine – Focus Diagnostica.
Dr Erik Briers is a past guest lecturer for the subject "Trends and Innovations in the Biomedical Sector" within the Master study programme Bio-Engineering at the University of Leuven Faculty of Engineering Technology 2009-2016 and is a science and medical writer.
Doctor Briers strong social involvement within patient organisations began after his own prostate cancer diagnosis in 2001 and successful radical prostatectomy treatment with no signs of recurrences until today.
He joined the Belgian patient support group "Us Too Belgium" and is one of the founders of EUROPA UOMO, the European Prostate Cancer Coalition. Today he is prostate cancer advocate and editor of the patient magazine "PROSTAATinfo" for the Belgian chapter.
He was the Executive Director of the European Cancer Patient Coalition (ECPC) (2012-2013) and Executive Director ad interim of EPPOSI (European platform for patient organisations science and industry) a multi-stakeholder think tank in health policy-making in 2014.
He is an alternate patient member of the Committee on Advanced Therapies (CAT) of the European Medicines Agency (EMA) (2016-2019). He is also patient member of the Guidelines Committee of the European Association of Urology (EAU) on prostate cancer.
Rahul Mandlik, PhD
Nicholas Broughton, BM BS MRCGP MFPM
Nick Broughton is the Managing Director of Ethos, a company specializing in education and behavioral change in the field of pharmaceutical ethics and compliance. He is a pharmaceutical physician with over 20 years of experience within the industry, including senior medical roles in the UK and European Medical and Regulatory Affairs for AstraZeneca and Celgene. He is actively involved in advising large and small pharmaceutical companies on their promotional and other activities.
Nick has post graduate qualifications in medical ethics and law from Keele University, UK. The educational program has been developed to draw heavy on theories of medical ethics and their practical application in business decision-making and commercial campaigns.
Nick is a member of the Faculty of Pharmaceutical Medicine Ethics and Practice Committee.
Helen Kane
Helen Kane is the Managing Director of PIVOT MSL, a specialist training consultancy with a core focus on driving excellence throughout the global MSL community.
A pharmacist by background she spent more than two decades working in medical affairs across the life science industry. With a strong track record in the development, management and leadership of MSL teams she was a founding member of the UK professional association for MSLs, and served as Chair 2012-15. Through her many activities she has acquired a reputation and profile as the leading, independent driving force behind the concept of MSL excellence. Respected as a trainer, facilitator, mentor, speaker and expert contributor, Helen believes that 'it is indeed a beautiful thing when a passion and a career come together.'
PIVOT MSL was established as a training consultancy from a belief in the value and impact of the MSL, and a desire to support the wider medical affairs community. Helen is proud to work with a team of selected industry experts who are connected by their desire to transform both individuals and teams. Distinguished by its expertise and a portfolio of innovative training programs for both MSLs and their leaders, PIVOT MSL is regarded as a trusted, go-to resource by clients throughout the world.
Michael Fronstin, MBA
Mr. Fronstin joined Kantar Health in 2005 and is currently the General Manager of the US Real World Evidence (RWE) Team. Mr. Fronstin is responsible for the commercial strategy, sales and operations, and new product creation and execution related to RWE. Additionally, Mr Fronstin is accountable for the Subject Matter Experts working with and satisfying clients.
As a member of Kantar Health's leadership team, Mr. Fronstin oversees the US Real-World Research and Value strategy initiative and the Patient Centered Research (PaCeR) Program; syndicated products such as the National Health and Wellness Survey, Epi Database® and integration of other available RWE, Kantar and WPP databases.
Mr. Fronstin has broad experience in the healthcare industry. Prior to joining Kantar Health he held various commercial and marketing positions at Humana, Merck & Company, the Johnson & Johnson/Merck joint venture, and TargetRx.
Mr. Fronstin earned a Master of Business Administration from the University of Miami with a focus on healthcare administration. He's been recognized as a thought leader in health outcomes as well as for various therapeutic areas.
Peter Gannon
With more than 20 years diversified experience in the life sciences industry, Peter has been involved in digital pharmaceutical communications since 1996. His leadership in strategic planning, revenue generation, and business partnering has established a strong and diverse client-base for Within3. He continues to work closely with existing and new clients as they expand use of Within3's solutions, introduce new use cases, and strive to push the envelope of innovation within their organizations engaging healthcare professionals, payers, and patients.
His expertise and experience in working closely with organizations to adopt new technologies proves invaluable to clients and partners. His consultative demeanor and willingness to work collaboratively continually provides benefits to clients and partners. Peter leads a team focused on driving market growth and new business nationally and globally by identifying and nurturing opportunities, forging close working relationships with clients and partners, and driving revenue for Within3.
Prior to his tenure at Within3, Peter was a part of the leadership team for Hyphen, an Omnicom-owned digital agency, Peter developed and implemented strategies that established Hyphen's market presence, grew product offerings, and drove business development and customer acquisition. Hyphen grew exponentially from 2003 to 2008, quadrupling staff and revenues while acquiring new clients and opportunities annually. Peter has also held positions with Sermo, Peer Direct, Torre Lazur, and Commonhealth developing business and leading accounts. Peter has worked extensively across the industry resulting in successful innovation for clients and customers alike.
Sabine Latour, MD
Omar Dabbous, MD, MPH
Omar has more than 25 years of leadership and strategic experience in HEOR, Market Access, Medical Affairs, Pharmacoepidemiology, and disease and safety registries in biotech, pharmaceutical, academia, and medical device settings. Currently, he is the VP, of HEOR & RWE at AveXis, a gene therpay company. Prior to joining AveXis he led the value and access activities at Halozyme. At GSK Omar developed and led the Global Value Evidence Analytics focusing on innovation and ensuring high quality of payer research including clinical trials and HEOR studies. Prior to joining GlaxoSmithKline he led the global health economics and outcomes research at Takeda, the Pharmacoepidemiology and Registry activities at J&J, and the Biostatistics/Epidemiology/Data Management and Analytics Departments at University of Massachusetts Medical School. He held a number of key industry roles and academic positions and is Adjunct Professor at the School of Pharmacy, University of Illinois, Chicago. Omar was recently recognized as one of the top 50 most influential people in Big Data. He is a leader in digital health. Omar is an author and co-author of more than 250 peer-reviewed publications.
Omar trained at Monastir School of Medicine in Tunisia, before taking his MPH at University of Massachusetts School of Public Health. He also has a Diploma in International Health and Medicine of Catastrophe from Tours Medical School in France. Omar also earned Certificates from Harvard University in Pharmacoeconomics and Outcomes Research and from Kellogg's School of Business in Business Marketing Strategies and Marketing Healthcare Products. He lived in 5 continents and is fluent in 4 languages.
Benit Maru, MBChB, PhD
Dr. Maru is an academic physician, Neuroimmunologist and health economist with extensive global experience in clinical research and development, translational medicine, health economics, real-world evidence, and medical affairs.
With a specialty in economic modeling and real-world evidence generation, Benit's scientific and industry career has primarily focused around neurology, neuroimmunology, immuno/haemato- oncology, and biological therapies for inflammatory diseases, nephrology, dermatology and rheumatology, and rare/ultra-rare disease.
Dan Simpson
João Dias, PhD
Dr. João Dias is an honors graduate of the University of Helsinki. He received his Licentiate/MSc in biochemistry from the Universities of Porto, Portugal and Wageningen, the Netherlands; and his PhD studies in Immuno-Oncology and Gene Therapy at Helsinki University Central Hospital and Helsinki University, faculty of Medicine.
He is currently responsible for international medical affairs and clinical development for the medical devices and diagnostics portfolio at Haemonetics which includes Hemostasis Management, Cell Salvage and Transfusion Management products. Prior to this role, João had a variety of roles of increasing responsibility in the areas of both market access and medical marketing.
He has authored several peer-reviewed publications and white papers in the fields of Hemostasis, Patient Blood Management, Immuno-Oncology, Gene Therapy, Hematology, and Molecular Biology.
Prior to his tenure at Haemonetics, João worked as a scientist in the development of new products in Cancer Gene Therapy and served as a Life Sciences Consultant working together with multiple global life-science companies."
Isabelle Bocher-Pianka
Isabelle Bocher -Pianka has over 25 years of international Management experience in the pharmaceutical and consumer goods industries, leading cross-functional and country teams across the globe. From her previous Senior Vice President role, leading the Global Neurosciences Franchise at Ipsen , she was appointed to the new transformation role of Chief Patient Affairs Officer reporting to Global Medical Affairs in March 2016
Her mission at Ipsen is to ensure that "the people we care about are at the center of the decisions we make."
She is the internal and external reference patient ambassador, responsible for driving and promoting the patient centricity vision and strategy along the entire value chain of Ipsen's therapeutic areas (Oncology, Neuroscience and Rare diseases) and across all divisions and geographies.
In developing Patient Centricity within the company, Isabelle supports the sourcing and internal dissemination of patient's insights, needs and priorities in order to shape Ipsen's business to positively impact patient outcomes.
Christian Schweiger, MD, PhD
Dr Schweiger is a senior medical affairs executive and pharmaceutical entrepreneur. He has led medical affairs for both multi-national and small pharmaceutical companies and has vast experience in building and selling pharmaceutical assets in small biotech organizations. He will be an ambassador for Medmeme across Europe
Lori Mouser, PharmD
Lori Mouser is the Global Head of Medical Science Liaisons (MSL) at F. Hoffman La Roche. She champions the success of MSLs to advance medicine through their engagements with healthcare providers. Leading MSL teams for over 17 years, Lori brings the experience from a range of therapeutic areas. She has US and Global exposure and operates with a commitment to creating solutions through collaboration.
Lori's first MSL position was at Aventis (now Sanofi) where she quickly gravitated to leading MSL teams during her 12 years with the company. Joining the Roche organization at Genentech in 2012, Lori ultimately had responsibility for the national US Oncology MSL and field leadership teams. Building upon that background, Lori expanded her scope in 2017 to serve the Roche global organization in her current role.
Lori holds a Doctor of Pharmacy Degree and prior to the pharmaceutical industry, she had an
academic career as an Associate Professor in Clinical Pharmacy at Washington State University.
Bertram Häussler
Bertram Häussler is the chairman of the IGES Group, a corporation of research and consulting companies specializing in infrastructure and health care. He is a medical doctor, sociologist, and honorary professor of Economics of the Pharmaceutical Industry at the Technical University (TU) Berlin. His research work focuses mainly on industrial economics, health services research, health economics, benefit assessment in medicine as well as drug development in a national and international context.
Annalaura Venturoli, MD
Nikolay Voznesenskiy, MD, PhD
Dr. Nikolay Voznesenskiy joined pharmaceutical industry 6 years ago after 18 years of experience in research and clinical practice in the respiratory medicine. Dr. Voznesenskiy made his research and PhD thesis on the topic "Exhaled nitric oxide as a biomarker of bronchial asthma" at the Pulmonology Research Institute (Russia).
He started a career in Medical Affairs at Chiesi as a Medical advisor. Then he moved to Medical Affairs of Boehringer Ingelheim. Currently Dr. Voznesenskiy is a Head of therapeutic area Respiratory at Medical Affairs of Boehringer Ingelheim Russia. Professional interests of Dr. Voznesenskiy are related to development of medical communication strategy, implementation of new approaches to external experts development and to continuous medical education.
Michael Hamann, PhD
Michael Hamann is Executive Director and European Head Scientific Affairs at Amgen, responsible for all medical education and scientific exchange activities across all of Amgen's therapeutic areas in Europe. He joined Amgen in 2005 as European Head for their Regional Medical Liaisons (RMLs). In 2008 he became Executive Director for Scientific Affairs building and leading the European Teams and Capabilities for Regional Medical Liaisons, Medical Communications, Medical Information, Scientific Publications, Training and Development and Patient Affairs. Michael has been working for more than 20 years in the pharmaceutical industry, and obtained his PhD in Physiology at the University of Marburg, Germany. He started his industry career at Eli Lilly in Germany in 1994 in diabetes research, and has held various management positions, including Head of Quality Assurance in manufacturing, responsibilities in Project Management and Medical Affairs.
Joseph B. Laudano
Joseph B. Laudano, BS Pharm, Pharm D, is Vice President, Medical Affairs Strategy at Medmeme LLC. Dr. Laudano has over 30 years' experience in the pharma industry. Before joining Medmeme, he was Vice President of Medical Affairs at Alliqua Biomedical. Before joining Alliqua Biomedical, Dr Laudano was Senior Director of Medical Affairs and head of Publication Planning at Forest Research Institute. Prior to this he spent 20 years at Roche Laboratories in Medical Affairs and Marketing in various roles including; Director of Medical Information, Product Director and Medical Liaison. Dr. Laudano has extensive research experience in several different therapeutic areas including infectious diseases, dermatology and oncology and has authored numerous publications and scientific posters.
Whether in research projects or project assignments, Dr. Laudano has always had a passion for recognizing trends and signals in data and product information. As director of Medical Information at Roche, he was the first to develop a qualitative reporting system on product inquiries which provided product teams trends in medical inquiries and other information. His passion for "analytical inquiry" serves him well at Medmeme where he works with the leadership team on developing Medical Affairs strategies and creating of new processes and applications for Medical Affairs Professionals.
When not at work, Dr. Laudano enjoys time with his wife, Kathleen and family. His hobbies include fishing, winemaking, cooking, gardening and wood working. He maintains a Master's Captains Licence and volunteers hundreds of hours each year as a coxswain, vessel examiner and aids to navigation verifier with the United States Coast Guard Auxiliary and has received numerous awards and commendations in this capacity.
Ove Schebye, MD
David McNaughton
David McNaughton has 23 years' experience in the Pharmaceutical industry working for a variety of small and large companies in therapy areas from vaccines to Oncology. It was during this time in Oncology at Pfizer that David attained his first insight into the importance and 'value' that MSL teams can bring, after seeing the huge impact they made on the successful introduction of Sutent for RCC & GIST patients.
Eleven years ago, David left Pfizer to set up STEM with Rob Wood, with the objective to help companies accelerate performance by 'benchmarking' their internal and external alignment to product plans. Initially this looked mainly at the Sales Teams alignment to strategy, messaging and execution, but over the last 4 or 5 years has evolved to also look at the Field Based Medical Expert role. This reflects the growing importance companies are placing on MSLs when it comes making sure the right patients are getting the right medicines as well as a growing desire to understand the 'value' these teams are adding.
The last 5 years have given us some very interesting 'benchmark' data that looks at what the MSLs believe their role to be, how it is evolving and how they then go about executing that role… and a great insight into how we might be able to benchmark 'value'.
Alexandra Giesen, DVM, MBA
Today, Medical Affairs must be more than just medicine.
Dr. Giesen is an independent medical affairs expert with the ability to combine medical profession and passion with business objectives.
She supports and advises pharmaceutical companies and external service providers within the pharmaceutical industry in the area of Medical Affairs, including medical product management and marketing, medical communication, MSL and medical information management. Her work focuses on conceptual strategy development and its operational and concrete implementation. She is motivated by her curiosity and her enthusiasm for both medical and entrepreneurial topics, for which she also likes to develop unconventional solutions.
Prior to her independent Medical Affairs business, Dr. Giesen gained nearly 15 years of experience as an employee within the pharmaceutical industry at Novartis Pharmaceuticals, Novartis Vaccines and GSK Vaccines. As Global Medical Director, Medical Advisor, MSL and Medical Affairs Project Manager in the national and international Medical Affairs business she was involved and showed extensive cross-functional leadership in numerous and diverse activities and projects within Medical Affairs, R&D, Marketing and Sales, Quality, RA, PV, Health Economy &Policy and Market Access.
Dr. Giesen is a certified veterinarian, has a doctorate degree in basic pharmacological research and holds an MBA in General Management.
Andrew Bruce
Andrew is a charismatic leader who has over 30 years' experience in the pharmaceutical industry in a variety of senior positions.
Working with top 10 pharma, specialty healthcare and biotech companies alike, Andrew has a passion for connecting the pharma industry with the people that matter: patients, decision makers and leaders of opinion to create strong and positive debate.
Creating enduring, transparent and ethical relationships throughout the development and launch processes for new products significantly improves the uptake and therefore patient access to new medicines. Tardis Medical has been built around developing tools, techniques and processes to enable positive peer-to-peer conversations, which enhance the reputation of the pharmaceutical industry.
This approach forms the foundations of Andrew's work consulting with Medical Affairs organisations globally, where his specialist areas of knowledge are; patient and HCP engagement and education, strategic developments in the role of the MSL and Operational Excellence, which includes systems, processes and MSL capabilities
Ian Greenway
Ian has over 30 years in pharmaceutical development and medical communications, including 4 years as a Medical Affairs Consultant to pharma and Medical Communication agencies and 10 years as a Global Medical Affairs Leader in AstraZeneca Oncology franchise delivering multinational communication programs. He has experience across many functions including Medical, Marketing, Operations and R&D.
Ian has extensive experience in the development of strategic medical plans for a number of oncology products and translation into effective multi-national programs to support communication to worldwide affiliate companies. He has led cross-functional teams to deliver insight-driven, customer-focused target product profile and claims documents to drive delivery of differentiated reimbursable medicines. Ian also has extensive experience in the delivery of medical excellence training programs to global and affiliate medical staff for a number of large Pharma companies. He now provide Medical Affairs expertise across the agency to support medical communication and training programs.
Sital Kotecha
Sital Kotecha has been in the role of Medical Affairs Strategy Director for Europe since July 2016. He is responsible for evolving and executing the Veeva Medical Strategy across Europe focussed on redefining the experience stakeholders have with the industry – with a lens on engagement, confidence build, evidence generation and deriving value from medical insights. He is also responsible for Events Management capabilities that span Medical and Commercial. He comes with Life Sciences experience having worked at AstraZeneca for 6 years in a variety of roles, most recently as Global IT Director for Global Medical Affairs & Global Commercial where he partnered with the function to deploy capabilities and processes to enable medical affairs to deliver on its business strategy both globally and locally. Prior to this role as Head of IT for the AstraZeneca UK where he led the rollout of Veeva CRM. He has 10 years of programme delivery experience with Accenture and started his career as a Pharmacist.
Rhiannon Meaden
Pamela M Peters, PhD
Dr Peters serves as Senior Director, Medical Affairs Strategic Solutions, a division of Medscape. She brings over 35 years of experience in medical affairs, medical education, research, and publishing to her work. After 15 years as a researcher focusing on immunological and oncological disorders, Pam turned her attention to the data-driven optimization of healthcare at which time she joined Medscape. Prior to her current role, she served as Senior Director, Oncology Education. Pam has a doctorate in immunology and genetics from Yale University and completed her post-doctoral work in immunology at University of California, Berkeley.
Anne Clare Wadsworth
Anne Clare brings a wealth of experience in pharmaceutical communications garnered during her 20 year career leading medical strategy and communication agencies. As Medical Affairs has evolved, Anne Clare has been at the forefront of innovation in agency delivery, transforming both approach and service offerings to address the expanding scope and requirements of Medical Affairs clients.
Having begun her career at Ashfield Healthcare Communications in 2000, Anne Clare supported multiple therapy areas and product launches prior to joining Envision Pharma Group in 2016 as part of the senior leadership team with a remit to expand the European medical strategy group. Having successfully grown the team, Anne Clare now leads a dedicated 45-strong group and has established a strong presence for Envision in the talent-rich hub of NW England.
With a keen interest in patient engagement, Anne Clare is one of the industry's leading proponents tackling the lack of consistent and evidence-based practices for patient partnership within life science communications as well as exploring how patient advocates and medical affairs teams can work in partnership towards shared goals. Last year, Anne Clare launched a new centre of excellence within Envision Pharma Group dedicated to Patient Partnership in Medical Affairs and Publications. Comprising a team of industry experts, the Envision the Patient team are leading the industry debate on the removal of barriers for patients wanting access to high quality, fair-balance scientific content.